Pathological findings of COVID-19 associated with acute respiratory distress syndrome-Reference-Cited by-同舟云学术

Pathological findings of COVID-19 associated with acute respiratory distress syndrome

Published:2020-04 Issue:4 Volume:8 Page:420-422
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Xu Zhe,Shi Lei,Wang Yijin,Zhang Jiyuan,Huang Lei,Zhang Chao,Liu Shuhong,Zhao Peng,Liu Hongxia,Zhu Li,Tai Yanhong,Bai Changqing,Gao Tingting,Song Jinwen,Xia Peng,Dong Jinghui,Zhao Jingmin,Wang Fu-Sheng

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference5 articles.

1. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

2. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020

3. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster;Chan;Lancet,2020

4. The clinical pathology of severe acute respiratory syndrome (SARS): a report from China;Ding;J Pathol,2003

5. Clinicopathologic, immunohistochemical, and ultrastructural findings of a fatal case of Middle East respiratory syndrome coronavirus infection in the United Arab Emirates, April 2014;Ng;Am J Pathol,2016

Cited by 6848 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conserved sequence features in intracellular domains of viral spike proteins;Virology;2024-11

2. Impact of anti-fibrotic medications on post-COVID-19 pulmonary fibrosis: A systematic review and meta-analysis;International Journal of Infectious Diseases;2024-10

3. A Review on Role of Inflammation in Coronavirus Disease;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-10

4. Impact of extracorporeal hemadsorption on mortality in critically ill COVID-19 patients in the intensive care unit;The International Journal of Artificial Organs;2024-09-13

5. Nebulized inhalation of plasma-activated water in the treatment of progressive moderate COVID-19 patients with antiviral treatment failure: a randomized controlled pilot trial;BMC Infectious Diseases;2024-09-12